INSMED INC Share Price
INSMED INC (INSM) had Share Price of $21.10 per share as of 2023-06-30, per its 10-K filed 2026-02-19.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:SharePrice · last filed 2026-02-19
- 2023-06-30: Share Price $21.10.
- 2023-01-31: Share Price $18.50.
- 2017-09-30: Share Price $28.50.
- 2017-09-06: Share Price $28.50.
| Period end | Share Price |
|---|---|
| 2023-06-30 | $21.10 10-K · filed 2026-02-19 |
| 2023-01-31 | $18.50 10-K · filed 2026-02-19 |
| 2017-09-30 | $28.50 10-K · filed 2020-02-25 |
| 2017-09-06 | $28.50 10-Q · filed 2017-11-02 |
| 2015-04-30 | $20.65 10-K · filed 2018-02-23 |
| 2015-04-06 | $20.65 10-Q · filed 2016-11-03 |
| 2014-08-31 | $11.25 10-K · filed 2017-02-23 |
| 2014-08-18 | $11.25 10-K · filed 2016-02-25 |
| 2013-07-22 | $10.40 10-K · filed 2016-02-25 |
| 2012-09-28 | $4.07 10-K · filed 2015-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |